Copyright: ©Author(s) 2026.
World J Gastroenterol. May 21, 2026; 32(19): 117166
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.117166
Published online May 21, 2026. doi: 10.3748/wjg.v32.i19.117166
Table 3 Initial treatment modalities and clinical outcomes of patients with eosinophilic gastroenteritis, n (%)
| Variable/outcome | Gastroduodenitis (n = 34) | Enterocolitis (n = 35) | Gastroenterocolitis (n = 4) |
| Initial treatment type | |||
| PPI | 9 (26.5) | 2 (5.7) | - |
| Steroid | 12 (35.3) | 23 (65.7) | 3 (75.0) |
| PPI + steroid | 5 (14.7) | 1 (2.9) | - |
| PPI + antihistamines | 1 (2.9) | - | - |
| PPI + steroid + antihistamines | 1 (2.9) | - | - |
| Steroid + antihistamines | - | 1 (2.9) | - |
| Antihistamines | - | 1 (2.9) | - |
| Conservative treatment | 6 (17.6) | 7 (20.0) | 1 (25.0) |
| Clinical outcomes | |||
| Clinical response | 27/32 (84.4) | 28/31 (90.3) | 3/4 (75.0) |
| Relapse | 4/29 (13.8) | 13/30 (43.3) | 0/4 (0) |
- Citation: Lee J, Kim SE, Cha RR, Lee BE, Choi CW, Jee SR. Presentation and treatment of eosinophilic gastroenteritis in Busan and Gyeongnam, Korea: A multicenter study. World J Gastroenterol 2026; 32(19): 117166
- URL: https://www.wjgnet.com/1007-9327/full/v32/i19/117166.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i19.117166